Published in Mol Cancer on February 04, 2010
Wapl is an essential regulator of chromatin structure and chromosome segregation. Nature (2013) 1.92
A centrosome-autonomous signal that involves centriole disengagement permits centrosome duplication in G2 phase after DNA damage. Mol Biol Cell (2010) 0.99
Rad51 regulates cell cycle progression by preserving G2/M transition in mouse embryonic stem cells. Stem Cells Dev (2014) 0.96
Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Genes Chromosomes Cancer (2013) 0.94
Targeting cell division cycle 25 homolog B to regulate influenza virus replication. J Virol (2013) 0.79
Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer. FEBS Open Bio (2013) 0.77
Overexpression of mutant cell division cycle 25 homolog B (CDC25B) enhances the efficiency of selection in Chinese hamster ovary cells. Cytotechnology (2013) 0.75
An oncogene-induced DNA damage model for cancer development. Science (2008) 11.60
Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer (2009) 11.25
Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol (2005) 4.80
Non-transcriptional control of DNA replication by c-Myc. Nature (2007) 4.55
Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage. Mol Cell Biol (2005) 4.54
ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol (2004) 4.39
Cdc25 cell-cycle phosphatase as a target of c-myc. Nature (1996) 4.23
Assembly of a complex containing Cdc45p, replication protein A, and Mcm2p at replication origins controlled by S-phase cyclin-dependent kinases and Cdc7p-Dbf4p kinase. Mol Cell Biol (2000) 3.52
CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer (2007) 3.46
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol (2001) 3.35
Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress. J Cell Biol (2006) 3.27
MCM2-7 complexes bind chromatin in a distributed pattern surrounding the origin recognition complex in Xenopus egg extracts. J Biol Chem (2002) 3.00
Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell (2004) 2.94
CDC25 phosphatases as potential human oncogenes. Science (1995) 2.84
Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell (2004) 2.64
Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J (2007) 2.44
The intra-S-phase checkpoint affects both DNA replication initiation and elongation: single-cell and -DNA fiber analyses. Mol Cell Biol (2007) 2.41
Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol (2006) 2.05
Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol (1999) 2.01
DNA replication and progression through S phase. Oncogene (2005) 1.99
Cdc25 phosphatases and cancer. Chem Biol (2004) 1.93
Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol Biol Cell (2007) 1.85
Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc Natl Acad Sci U S A (2008) 1.74
Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol (2005) 1.63
Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol (1999) 1.59
CDK- and Cdc45-dependent priming of the MCM complex on chromatin during S-phase in Xenopus egg extracts: possible activation of MCM helicase by association with Cdc45. Genes Cells (2003) 1.57
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc Natl Acad Sci U S A (2005) 1.55
Chromatin decondensation in S-phase involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation. J Cell Biol (2005) 1.37
Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem (2005) 1.35
The mammalian DNA replication elongation checkpoint: implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analyses. Cell Cycle (2007) 1.34
Cell cycle control by the CDC25 phosphatases. Anticancer Agents Med Chem (2008) 1.22
Interactions of human Cdc45 with the Mcm2-7 complex, the GINS complex, and DNA polymerases delta and epsilon during S phase. Genes Cells (2007) 1.20
Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J Biol Chem (1997) 1.09
Regulation of CDC25B phosphatases subcellular localization. Oncogene (2000) 1.09
Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells. Mol Biol Cell (2003) 1.08
CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation. Cancer Res (2007) 1.06
Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J Cell Sci (2004) 1.05
Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Oncogene (2007) 1.04
Induction of Cdc25B regulates cell cycle resumption after genotoxic stress. Cancer Res (2007) 1.01
Apoptosis induced by replication inhibitors in Chk1-depleted cells is dependent upon the helicase cofactor Cdc45. Cell Death Differ (2008) 0.99
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Mol Cancer Ther (2006) 0.99
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. Cell Cycle (2008) 0.92
Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects. Int J Cancer (1998) 0.86
Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene (2007) 0.85
Constitutive overexpression of CDC25A in primary human mammary epithelial cells results in both defective DNA damage response and chromosomal breaks at fragile sites. Int J Cancer (2008) 0.82
Phosphorylation of CDC25C at S263 controls its intracellular localisation. FEBS Lett (2007) 0.80
Inappropriate activation of cyclin-dependent kinases by the phosphatase Cdc25b results in premature mitotic entry and triggers a p53-dependent checkpoint. J Biol Chem (2009) 0.78
CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer (2007) 3.46
The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett (2002) 2.30
The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol (2006) 2.28
Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition. J Cell Sci (2004) 1.93
Pharmacological inhibition of aurora-A but not aurora-B impairs interphase microtubule dynamics. Cell Cycle (2009) 1.48
The cell cycle regulator CDC25A is a target for JAK2V617F oncogene. Blood (2011) 1.47
3D imaging of the response to CDC25 inhibition in multicellular spheroids. Cancer Biol Ther (2009) 1.45
Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1. J Cell Biol (2009) 1.41
Multicellular tumor spheroid model to evaluate spatio-temporal dynamics effect of chemotherapeutics: application to the gemcitabine/CHK1 inhibitor combination in pancreatic cancer. BMC Cancer (2012) 1.28
Cell cycle control by the CDC25 phosphatases. Anticancer Agents Med Chem (2008) 1.22
OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol (2009) 1.19
CDC25B phosphorylation by Aurora-A occurs at the G2/M transition and is inhibited by DNA damage. Cell Cycle (2005) 1.18
CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci (2006) 1.16
Live cell division dynamics monitoring in 3D large spheroid tumor models using light sheet microscopy. Cell Div (2011) 1.12
Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene (2002) 1.11
Breast cancer-associated Abraxas mutation disrupts nuclear localization and DNA damage response functions. Sci Transl Med (2012) 1.07
CDC25B involvement in the centrosome duplication cycle and in microtubule nucleation. Cancer Res (2007) 1.06
Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity. Bioorg Med Chem (2005) 1.03
Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy. Cancer Res (2009) 1.03
Interaction of p21(CDKN1A) with PCNA regulates the histone acetyltransferase activity of p300 in nucleotide excision repair. Nucleic Acids Res (2008) 1.01
Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene (2003) 1.00
Genotoxic-activated G2-M checkpoint exit is dependent on CDC25B phosphatase expression. Mol Cancer Ther (2006) 0.99
The polo-like kinase 1 regulates CDC25B-dependent mitosis entry. Biochim Biophys Acta (2009) 0.98
Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D. BMC Cancer (2013) 0.95
Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. J Chem Inf Model (2007) 0.94
What's new on CDC25 phosphatase inhibitors. Pharmacol Ther (2007) 0.94
CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle (2005) 0.94
A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses. Cell Rep (2013) 0.93
p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition. Cell Cycle (2003) 0.93
Characterization of the antiproliferative activity of Xylopia aethiopica. Cell Div (2012) 0.92
Moderate variations in CDC25B protein levels modulate the response to DNA damaging agents. Cell Cycle (2008) 0.92
CDC25B phosphorylation by p38 and MK-2. Cell Cycle (2006) 0.91
Deep and clear optical imaging of thick inhomogeneous samples. PLoS One (2012) 0.91
Distinct pools of proliferating cell nuclear antigen associated to DNA replication sites interact with the p125 subunit of DNA polymerase delta or DNA ligase I. Exp Cell Res (2004) 0.90
Identification of an unexpected link between the Shh pathway and a G2/M regulator, the phosphatase CDC25B. Dev Biol (2006) 0.90
Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Mol Cancer Ther (2005) 0.89
IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. Int J Cancer (2009) 0.88
Linking PCNA-dependent replication and ATR by human Claspin. Biochem Biophys Res Commun (2007) 0.88
Mechanical stress impairs mitosis progression in multi-cellular tumor spheroids. PLoS One (2013) 0.88
A screen for deubiquitinating enzymes involved in the G₂/M checkpoint identifies USP50 as a regulator of HSP90-dependent Wee1 stability. Cell Cycle (2010) 0.87
Inhibitors of the CDC25 phosphatases. Prog Cell Cycle Res (2003) 0.87
The CDC25B phosphatase shortens the G2 phase of neural progenitors and promotes efficient neuron production. Development (2012) 0.86
Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis. J Biol Chem (2002) 0.85
Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. Bioorg Med Chem Lett (2005) 0.84
Asymmetric localization of the CDC25B phosphatase to the mother centrosome during interphase. Cell Cycle (2007) 0.84
Evaluation of checkpoint kinase targeting therapy in acute myeloid leukemia with complex karyotype. Cancer Biol Ther (2012) 0.83
Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia. Eur J Pharmacol (2008) 0.83
Mitotic phosphorylation of Cdc25B Ser321 disrupts 14-3-3 binding to the high affinity Ser323 site. J Biol Chem (2010) 0.83
A novel synthetic inhibitor of CDC25 phosphatases: BN82002. Cancer Res (2004) 0.83
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci. PLoS One (2013) 0.83
Pharmacologic inhibition of CDC25 phosphatases impairs interphase microtubule dynamics and mitotic spindle assembly. Mol Cancer Ther (2007) 0.82
NanoLC-MS/MS analysis provides new insights into the phosphorylation pattern of Cdc25B in vivo: full overlap with sites of phosphorylation by Chk1 and Cdk1/cycB kinases in vitro. J Proteome Res (2008) 0.82
PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation. Biol Cell (2003) 0.80
A versatile sample holder for single plane illumination microscopy. J Microsc (2013) 0.80
Phosphorylation of CDC25C at S263 controls its intracellular localisation. FEBS Lett (2007) 0.80
Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery. Cancer Res (2011) 0.79
UV-induced downregulation of the CDC25B protein in human cells. FEBS Lett (2010) 0.79
Human CDC25B and CDC25C differ by their ability to restore a functional checkpoint response after gene replacement in fission yeast. Biochem Biophys Res Commun (2002) 0.78
LIM-only protein FHL3 interacts with CDC25B2 phosphatase. Exp Cell Res (2003) 0.78
Evolutionary conservation of a novel splice variant of the Cds1/CHK2 checkpoint kinase restricted to its regulatory domain. Cell Cycle (2004) 0.78
Cell adhesion regulates CDC25A expression and proliferation in acute myeloid leukemia. Cancer Res (2006) 0.78
Study of the docking-dependent PLK1 phosphorylation of the CDC25B phosphatase. Biochem Biophys Res Commun (2011) 0.78
CDC25B associates with a centrin 2-containing complex and is involved in maintaining centrosome integrity. Biol Cell (2011) 0.78
A new mitotic-cell specific monoclonal antibody. Cell Cycle (2007) 0.78
[Bacterial cyclostatin, or how do bacteria manipulate the eukaryotic cell cycle]. Med Sci (Paris) (2003) 0.78
What similarity between human and fission yeast proteins is required for orthology? Yeast (2002) 0.77
Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties. Bioorg Med Chem (2008) 0.77
Synthesis of small molecule CDC25 phosphatases inhibitors. Bioorg Med Chem Lett (2004) 0.76
Cell cycle-dependent localization of CHK2 at centrosomes during mitosis. Cell Div (2013) 0.76
Ability of human CDC25B phosphatase splice variants to replace the function of the fission yeast Cdc25 cell cycle regulator. FEMS Yeast Res (2004) 0.76
Structure Tensor Based Analysis of Cells and Nuclei Organization in Tissues. IEEE Trans Med Imaging (2015) 0.76
Microdevice arrays of high aspect ratio poly(dimethylsiloxane) pillars for the investigation of multicellular tumour spheroid mechanical properties. Lab Chip (2014) 0.76
The "starter" and "gas pedal" of mitosis reside at the centrosome. Commentary on "characterization of centrosomal localization and dynamics of CDC25C phosphatase in mitosis" by Bonnet et al. Cell Cycle (2008) 0.75
5-Substituted [1]pyrindine derivatives with antiproliferative activity. Eur J Med Chem (2009) 0.75
Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide. Eur J Med Chem (2012) 0.75
A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25. Curr Genet (2004) 0.75
Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells. Development (2016) 0.75
Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors. ChemMedChem (2009) 0.75